| |
| |
|
| Insider
Information: |
Rieflin William Jl |
| Relationship: |
|
| City: |
So. San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
18,000 |
|
|
Indirect Shares
|
76,722 |
|
|
| Direct
Value |
$72,900 |
|
|
|
Indirect Value
|
$310,724 |
|
|
| Total
Shares |
94,722 |
|
|
| Total
Value |
$383,624 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 103.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenoport Inc |
XNPT |
Director |
2016-07-05 |
0 |
2016-07-05 |
0 |
Premium* |
|
|
Ngm Biopharmaceuticals Inc |
NGM |
|
2024-04-05 |
0 |
2024-04-05 |
0 |
Premium* |
|
|
Rapt Therapeutics, Inc. |
RAPT |
|
2020-11-19 |
18,000 |
2020-11-19 |
76,722 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XNPT |
Xenoport Inc |
Director |
– • – |
2015-05-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
26,660 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2016-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
31,660 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2016-07-05 |
4 |
D |
$7.03 |
$222,570 |
D/D |
(31,660) |
0 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2016-07-05 |
4 |
D |
$7.03 |
$1,976,731 |
I/I |
(281,185) |
0 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Executive ChairmanOfficer |
• • – |
2019-04-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,712,500 |
|
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Executive Chairman |
• • – |
2019-04-08 |
4 |
A |
$0.00 |
$0 |
I/I |
56,668 |
2,769,168 |
0 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
Director |
– • – |
2019-10-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
16,666 |
|
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
Director |
– • – |
2019-11-04 |
4 |
A |
$0.00 |
$0 |
I/I |
60,056 |
76,722 |
0 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
Director |
– • – |
2019-11-04 |
4 |
B |
$12.00 |
$96,000 |
D/D |
8,000 |
8,000 |
2.39 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
|
– • – |
2020-11-19 |
4 |
B |
$16.22 |
$162,200 |
D/D |
10,000 |
18,000 |
0.01 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
|
– • – |
2024-04-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,172) |
0 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
|
– • – |
2024-04-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,769,168) |
0 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
